Come up with a name for your new list and we'll add to it:
Signum Biosciences raised a round of funding on September 17, 2007. Investors include
New Jersey Commission on Science & Technology.
Signum Biosciences is a biotechnology company dedicated to developing small-molecule therapeutics derived from the Signal Transduction Modulation (STM) platform to modulate signal transduction imbalan…